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Abstract Highly purified adenylate translocase (ANT) from rat
heart mitochondria was functionally reconstituted as ATP/ADP
exchange carrier in asolectin/cardiolipin vesicles. The ANT
preparations used were free of porin, cyclophilin D, and Bax as
analysed immunologically and by activity measurements. After
pre-loading the ANT-containing proteoliposomes with ATP,
malate or AMP, a gradual release of the trapped compounds by
increasing the external Ca2+ concentrations could be demon-
strated. N-Methyl-Val-4-cyclosporin did not inhibit the Ca2+
dependent release of internal substances from ANT liposomes.
This inhibitor was found to be specific for the mitochondrial
permeability transition pore (MTP) in intact mitochondria or
reconstituted MTP-like protein complexes (e.g. hexokinase,
porin, ANT complex). However, ADP in concentrations s 20
WM inhibited the liberation of internal compounds, while in
contrast, atractyloside (30 WM) and HgCl2 (5 WM) both induced
permeability of the ANT-containing liposomes resulting in a
release of trapped substances. These results strongly suggest that
ANT itself is capable to adopt a pore-like structure under
conditions known to induce the permeability transition in
mitochondria.
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1. Introduction
Mitochondria from a variety of sources exhibit a Ca2-de-
pendent increase of inner membrane permeability for mole-
cules with Mr 6 1500 Da, the ‘permeability transition’. Re-
sponsible for this behavior is a regulated inner membrane
channel, the mitochondrial permeability transition pore
(MTP). Pore opening is dependent on the transmembrane
potential di¡erence, on matrix pH, redox state of SH groups
and a variety of e¡ectors acting on multiple sites within the
mitochondrion (for reviews see [1^3]). Cyclosporin A (CsA)
[4] is a very potent (apparent I50 in the range of 50 nM)
selective inhibitor of the MTP.
In recent publications, evidence was presented indicating
that mitochondrial permeability transition constitutes an im-
portant step in the apoptotic process. In a cell free system
containing isolated mitochondria and nuclei, opening of the
MTP was necessary to induce DNA fragmentation typical for
nuclear apoptosis [5,6].
So far, the proteins constituting the channel are not known.
The observation by Halestrap et al. [7,8] that atractyloside
opened the MTP, while bongkrekate and ADP closed it, led
to the assumption that ANT could be at least one constituent
of the channel. In agreement to this, Brustovetsky and Klin-
genberg [9] recently provided evidence by patch-clamping that
isolated ANT reconstituted in liposomes could form high-con-
ductance channels in the presence of Ca2. Similar high con-
ductance channels have been characterised in patch clamped
mitochondrial membranes and were found to be CsA sensitive
[10]. While investigating the association of kinases with porin
at the mitochondrial contact sites [11,12], we recently isolated
two complexes enriched either in a hexokinase tetramer, porin
and ANT, or in a mitochondrial creatine kinase octamer,
porin and ANT. When reconstituted into liposomes or black
lipid membranes, the hexokinase/porin/ANT complex con-
ferred to the system permeability and conductance properties
that resembled those of the MTP [13]. Indeed, when the pro-
teoliposomes were pre-loaded with malate or ATP, a gradual
release by increasing Ca2 of the trapped compound could be
demonstrated. As is speci¢c for the MTP, the £ux through
these protein complexes was inhibited by CsA or by N-meth-
yl-Val-4-cyclosporin [13], a CsA derivative which binds to and
inhibits mitochondrial cyclophilin (CyP D), but not calcineur-
in [14,15]. Proteoliposomes containing the creatine kinase/por-
in/ANT complex did not display MTP-like properties unless
the octamer of the creatine kinase [16] was dissociated into
dimers [17]. It was observed that ligands of creatine kinase,
inducing the octamer, and of hexokinase, such as glucose and
ATP, inhibited MTP-like behaviour [17,18]. As shown earlier,
CyP D co-puri¢es with the hexokinase/porin/ANT complex,
but was absent in the creatine kinase/porin/ANT complex [18].
We thus concluded that ANT is the channel forming unit that
is regulated either by interaction with porin and cyclophilin or
direct with the mitochondrial creatine kinase octamer. The
results obtained here with puri¢ed and reconstituted ANT
indicate that this ATP/ADP antiporter carrier protein can in-
deed form an unspeci¢c uniporter for small molecules and
thus, by itself, seems to constitute the key element of the
MTP.
2. Materials and methods
2.1. Chemicals
If not otherwise indicated, chemicals were all bought from Boehr-
inger-Mannheim and Merck-Darmstadt, Germany. N-Methyl-Val-4-
cyclosporin was a generous gift of Dr. Roland Wenger of Sandoz
Pharma AG, Basel, given to us by Prof. P. Bernardi, University of
Padua.
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2.2. Antibodies
The monoclonal antiserum against the N-terminus of human type I
porin was bought from Calbiochem. The antibodies against Bax were
bought from Santa Cruz Biotec. Speci¢c antibodies against cyclo-
philin D were a gift from P. Bernardi, Padova. The polyclonal anti-
bodies against adenylate translocase from chicken heart were prepared
as described [19].
2.3. Enzyme assays
Peptidyl-prolyl-cis-trans isomerase (EC 5.2.1.8, cyclophilin) ac-
tivity was determined by optical test according to Schutkowski et
al. [20].
2.4. Substrate tests
Malate, AMP, NAD and ATP concentrations were also determined
enzymatically according to Bergmeyer [21].
2.5. Isolation of adenylate translocase from rat heart muscle
A modi¢ed isolation procedure for the ATP/ADP carrier protein,
resulting in highly enriched ANT (Dolder and Wallimann, unpub-
lished), was used here. All steps were carried out at 0^4‡C. In short,
heart mitochondria were prepared from 5 rat hearts by Waring blen-
der homogenisation and di¡erential centrifugation in a medium con-
taining 220 mM mannitol, 70 mM sucrose, 10 mM HEPES, 0.2 mM
EDTA and 1 mM mercaptoethanol, pH 7.4. Isolated heart mitochon-
dria (20 mg) within 1 ml of isolation medium were incubated for 5 min
with an equal volume of extraction bu¡er, consisting of 40 mM
KH2PO4, 40 mM KCl, 2 mM EDTA and 6% Triton X-100, pH
6.0. The suspension was centrifuged for 30 min at 24 000Ug and
the supernatant was loaded on a column ¢lled with 1 g of dry
hydroxyapatite (Bio-Rad). After elution with extraction bu¡er, the
£ow-through fraction was collected and diluted 1:1 with column bu¡-
er (20 mM MES, 0.2 mM EDTA, 0.5% Triton X-100, pH 6.0). This
sample was applied to a 1-ml ‘HiTrapSP’ cation exchanger column
(Pharmacia), connected to an FPLC system, and eluted by an NaCl
gradient (0^1 M NaCl in column bu¡er). The fractions were analysed
by sodium dodecyl sulphate (SDS), 12% polyacrylamide gel electro-
phoresis (PAGE) according to Laemmli [22] and by immuno decora-
tion with speci¢c antibodies against ANT, porin, CyP D, and Bax
after transfer to nitrocellulose sheets.
2.6. Isolation and reconstitution of the hexokinase-porin-ANT complex
Isolation and reconstitution of the hexokinase-porin-ANT complex
was performed as described recently [13].
2.7. Reconstitution of ANT in liposomes
Puri¢ed ANT was reconstituted in asolectin vesicles containing 2%
cardiolipin. The ANT fractions were mixed with the liposomes and
dialysed overnight against 125 mM sucrose, 10 mM HEPES, pH 7.4.
The vesicles were loaded with 5 mM ATP or 5 mM metabolites
(NAD, AMP, malate) plus 10 mM KCl by soni¢cation and extracel-
lular ATP or malate was subsequently removed by chromatography
on Sephadex G50 in 125 mM sucrose, 10 mM HEPES. After chro-
matography, the permeability for ATP or malate was tested by cen-
trifugation for 30 min at 400 000Ug and subsequent determination of
the substrates in the supernatant and sediment fraction.
2.8. Analysis of the adenylate translocase function
ATP plus KCl loaded liposomes containing reconstituted ANT
were suspended in 125 mM sucrose, 10 mM HEPES, pH 7.4. The
vesicles were analysed for ATP release by incubation for 30 min at
room temperature with ADP in the range between 50 and 1000 WM.
After incubation the vesicles were centrifuged as described above and
the liberated ATP was determined enzymatically in the supernatant.
ATP release was also measured in the presence of atractyloside in a
concentration twice that of ADP.
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Fig. 1. Characterisation of the puri¢ed ANT by PAGE and speci¢c antibodies. A: SDS-polyacrylamide gel electrophoresis (PAGE) stained
with Coomassie Blue was performed with fractions representing di¡erent steps of the ANT isolation procedure described in Section 2: 3% Tri-
ton extract of mitochondrial membrane (Triton extr), the ¢rst HTP column (lane 1) and ¢nal ANT fraction after cation exchange chromatogra-
phy (HiTrap, lane 2) and after reconstitution in liposomes (Liposomes). B: The polypeptides separated by PAGE (shown in A) were electro-
transferred onto a nitrocellulose blotting membrane which was subsequently decorated by speci¢c antibodies against ANT (anti-ANT; A), porin
(anti-Porin), Bax (anti-Bax) or cyclophilin (anti-Cyclophilin).
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2.9. Measuring the permeability transition pore
Metabolite (malate, NAD, AMP) and KCl loaded liposomes con-
taining reconstituted ANT were suspended in 125 mM sucrose, 10
mM HEPES, pH 7.4. The vesicles were analysed for metabolite lib-
eration by incubation for 30 min at room temperature in the presence
of Ca2 between 0 and 500 WM. The liberated substances were deter-
mined enzymatically in the supernatant after centrifugation as de-
scribed above.
3. Results
3.1. Isolation and characterisation of the adenylate translocase
The puri¢ed ANT fraction used for reconstitution in lip-
osomes was almost free of contaminating polypeptides as
shown by PAGE in Fig. 1A (lane 2). The ANT fraction con-
tained mainly two bands at 30 and 65 kDa that correspond to
the monomer and dimer of ANT as shown by immuno dec-
oration of puri¢ed ANT as well as reconstituted ANT in lip-
osomes (Fig. 1A). Analysis of the PAGE transblots by speci¢c
antibodies, anti-porin, anti-cyclophilin, anti-Bax demon-
strated the absence of porin, cyclophilin and Bax in the ¢nal
ANT fraction (Fig. 1B). During the di¡erent steps of the
preparation procedure, cyclophilin activity was also examined.
Mitochondrial cyclophilin (0.2 mU/mg) was found in the ex-
tract of disrupted mitochondria but was removed during ANT
preparation presumably by the high ionic strength that was
used during column chromatography.
3.2. Reconstitution of the adenylate translocase in liposomes
3.2.1. Function of ANT as adenine nucleotide antiporter.
ANT was reconstituted in asolectin/cardiolipin liposomes. The
vesicles were loaded with 5 mM ATP that remained inside, as
was proven by centrifugation. After addition of external ADP,
however, the internal ATP was gradually released (Fig. 2A).
As expected for an obligate antiporter, the amount of ATP
released correlated with the increasing concentrations of ex-
ternally added ADP. This process was inhibited by atractylo-
side present in a 2:1 ratio to ADP. As atractyloside acts as a
competitive inhibitor for ADP and ATP, the addition of dou-
ble concentrations of inhibitor vs. nucleotide does not result
in a complete inhibition. The S.D. of the mean values in the
presence of atractyloside, shown in Fig. 2A, was always to-
wards zero and never above the mean value. In summary, the
results clearly suggest a functionally competent reconstitution
of ANT as ATP/ADP exchange carrier. The release of ATP
by external ADP did not exceed more than 60% of total ATP
in the vesicle fraction. This agrees with the observation of
Ca2-dependent malate liberation shown below. It may be
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Fig. 2. Function of the reconstituted ANT as ATP/ADP-antiporter
and as unspeci¢c uniporter. A: Isolated ANT was reconstituted in
liposomes as described in Section 2. The liposomes were loaded
with 5 mM ATP plus 10 mM KCl. ATP was liberated from the
vesicles by external addition of di¡erent concentrations of ADP as
indicated (b). Speci¢c inhibition of the antiport activity was meas-
ured with ADP plus atractyloside at 1:2 molar ratio (E). The results
are means of four experiments. B: ANT containing proteoliposomes
were generated and loaded with malate plus KCl as described in
Section 2. The release of trapped malate by di¡erent Ca2 concen-
trations is shown as % of total malate content in the vesicles as de-
termined after solubilisation with Triton. Mean values and S.D. of
4 experiments. C: The hexokinase-porin-ANT complex that con-
tained cyclophilin was isolated and reconstituted in vesicles as de-
scribed recently [13]. These vesicles and in parallel proteoliposomes
containing puri¢ed ANT only, as in B, were loaded with malate
and preincubated with concentrations of methyl-Val-4-cyclosporin
between 10 and 150 nM. Subsequently, malate was released by 500
WM Ca2 that was adequate to liberate between 50 and 60% of the
total malate (shown in B). The inhibition is expressed as 100-% of
malate that was set free by 500 WM Ca2. Data are means of three
experiments in case of ANT. Note: Ca2-dependent malate release
from ANT liposomes is not inhibited by cyclosporin.
C
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explained by the assumption that approximately 50% of ANT
has been functionally reconstituted.
3.2.2. Function of ANT as unspeci¢c uniporter. To study
the function of ANT as unspeci¢c uniporter, the proteolipo-
somes were loaded with malate. Fig. 2B shows that the
trapped malate could be released from the vesicles by the
addition of Ca2 concentrations ranging between 50 and
500 WM. The opening of the reconstituted ANT by 500 WM
Ca2 was not inhibited by N-methyl-Val-4-cyclosporin in a
concentration range between 10 and 150 nM (Fig. 2C). In
contrast N-methyl-Val-4-cyclosporin in the same concentra-
tions inhibited (I50 = 20 nM) the permeation through ANT
in the reconstituted hexokinase complex. In this complex
that was isolated as described recently [13], ANT is coupled
to porin and cyclophilin [18] and thus may have a di¡erent
structure.
The Ca2-dependent liberation of malate from the proteo-
liposomes was in£uenced by ANT ligands in the same way as
already observed by Halestrap et al. [7] in isolated mitochon-
dria. Between 50 and 100 WM ADP inhibited the liberation of
malate induced by 500 WM Ca2 (Fig. 3A), while atractyloside
was able to open the channel (Fig. 3B). As observed recently
[17], the atractyloside action in the presence of low Ca2 had
a maximum e¡ect at 15^20 WM, while higher or lower con-
centrations of the same compound were less e¡ective in chan-
nel opening. In the present experiment, we observed a max-
imal release of malate at 30 WM atractyloside, in the presence
of 50 WM Ca2 (Fig. 3A), which on its own had no such e¡ect
(see Fig. 2B). Dierks et al. (1990) were able to reversibly
modify the aspartate/glutamate carrier and ANT from obli-
gate counter-exchange to uni-directional transport by block-
ing SH-groups with mercury reagents [23,24]. According to
the authors’ results, the intrinsic channel appeared to be a
structural requirement of the exchange carrier-mediated trans-
port. In support of this idea, Petronilli et al. [25] reported that
the permeability transition is tuned by the oxidation-reduction
state of thiol groups. As shown in Fig. 3A, addition of HgCl2
in concentrations between 2 and 8 WM to our loaded ANT
vesicles led to increasing release of the trapped AMP, or NAD
or malate up to 60%. This e¡ect was completely abolished by
the presence of 2.5 mM mercaptoethanol.
4. Discussion
The results described above suggest that ANT can reversi-
bly adopt two conformations that cause two functions of the
protein to act either as a speci¢c ATP/ADP exchange carrier
or as an unspeci¢c channel. As shown by Dierks et al. [23,24]
and Schroers et al. [26], this reversible transformation into
uniporter function appears to be speci¢c for a number of
mitochondrial exchange carriers such as ANT, aspartate/glu-
tamate- and phosphate/OH3 exchanger. In all cases, dimers of
the proteins which have 6 transmembrane helices in each
monomer, form the active transport unit. The reversible anti-
port-uniport conversion of the phosphate carrier, for example,
depends on the presence of one single cysteine (cysteine 28) in
the monomer, that are two cysteines in the functionally active
dimer [26]. Our results showing initiation of malate release
through ANT by HgCl2 fully corroborated those of Dierks
et al. [23,24]. The results furthermore suggested that, gener-
ally, all mitochondrial exchange carriers may be able to be
transformed into mitochondrial permeability transition pores.
The question of whether high [Ca2] can induce antiport-uni-
port conversion of some or all of these mitochondrial ex-
change carriers, such as observed here for the reconstituted
ANT (Fig. 2B), has not yet been answered.
Cyclophilin D, the target for cyclosporin, was not present in
our reconstituted ANT. ANT conferred the vesicles with
Ca2-induced permeability properties that resembled those
of the MTP. In agreement with the results of Brustovetsky
and Klingenberg [9], this suggested that the presence of cyclo-
philin was not required for MTP-like behaviour (Fig. 2B).
However, ANT coupled to porin, as in the hexokinase com-
plex, appeared to be di¡erent. It needed cyclophilin for Ca2-
dependent opening. If the cyclophilin was removed by cyclo-
sporin, MTP-like behaviour of the hexokinase-porin-ANT
complex was suppressed (Fig. 2C).
It has been shown that ANT builds complexes with porin,
hexokinase and/or creatine kinase [13,17]. ADP, the product
of these kinases [18], in physiological concentrations of 20^50
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Fig. 3. Regulation of the uniporter activity of reconstituted ANT by
speci¢c ligands and SH-groups. A: Vesicles loaded with 5 mM ma-
late, or AMP, or NAD and 10 mM KCl were incubated with di¡er-
ent HgCl2 concentrations as indicated. In one experiment 5 WM
HgCl2 was added in the presence of 2.5 mM mercaptoethanol
(5+ME). The e¡ect of ADP was studied by pre-incubation of the
vesicles with di¡erent ADP concentrations as indicated. Subse-
quently, 500 WM Ca2 was added. This concentration was su⁄cient
to release 50^60% of the total malate in the absence of ADP (see
Fig. 2B). B: The e¡ect of di¡erent atractyloside concentrations on
the malate loaded vesicles was studied in the presence of 50 WM
Ca2 that, by itself, was not adequate to release more than 10%
malate (see Fig. 2B). The malate release is shown as % of total ma-
late determined after solubilising the vesicles by Triton. A,B: mean
values of 3 experiments.
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WM, inhibited the Ca2-dependent conversion of ANT into a
uniport channel (Fig. 3A). Therefore, physiologically, the uni-
port conversion of ANT would occur only at low ADP and
substrate levels, e.g. glucose or creatine, for these kinases.
However, at high substrate levels still other antiporters, such
as the aspartate/glutamate carrier, may be ready to perform
mitochondrial permeability transition.
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